3-D Matrix, Ltd.
Details of the 2026 Full-Year Financial Results and Medium-Term Management Plan ｜ July 17, 2026
The full-year financial results for the fiscal year ending April 2026 show sales figures that are unknown, with operating profits in the U.S., Europe, and Japan being either positive or negative. The medium-term plan aims for increased sales by April 2027, with gastrointestinal field driving growth. Progress in the U.S. and Europe, as well as organizational changes, are also reported.
Key Figures
- Sales: Unknown (FY2026 Q4 data not provided)
- U.S. Q4 sales increase: approximately 30%
- European operating profit: profit
- Japanese operating profit: loss
- Number of employees: 129 (end of FY2026) → planned 139 (end of FY2027)
AI要約
Performance Overview
The financial results for the fiscal year ending April 2026 show an approximately 30% increase in Q4 due to rising sales and new account openings in the U.S. Europe generally progressed according to budget, particularly in the gastrointestinal field, turning to profit. Meanwhile, Japan experienced a loss due to headquarters common costs. Overall, the company maintains high growth, while strengthening organizational structures and making strategic investments for future expansion.
Future Outlook and Strategy
The medium-term management plan sets a high-growth sales target for FY2027, with a focus on expanding the gastrointestinal field as the main driver. In the U.S., gastrointestinal penetration remains low at 15–20%, offering substantial growth potential. In Europe, new needs in otolaryngology and urology are expected to generate sustainable growth. The company is also revising its organizational structure and strengthening sales operations, with an increase in employees planned for FY2027.
Three-D Matrix Corporation
Company overview · Stock price · Financial data · All IR
